Zeke Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $563K | Buy |
780
+292
| +60% | +$211K | 0.04% | 224 |
|
|
2022
Q3 | $337K | Buy |
488
+10
| +2% | +$6.91K | 0.02% | 289 |
|
|
2022
Q2 | $283K | Buy |
478
+19
| +4% | +$11.2K | 0.02% | 342 |
|
|
2022
Q1 | $320K | Buy |
+459
| New | +$320K | 0.02% | 354 |
|
|
2020
Q1 | – | Sell |
-1,263
| Closed | -$474K | – | 455 |
|
|
2019
Q4 | $474K | Buy |
1,263
+34
| +3% | +$12.8K | 0.04% | 392 |
|
|
2019
Q3 | $341K | Buy |
1,229
+6
| +0.5% | +$1.67K | 0.03% | 427 |
|
|
2019
Q2 | $383K | Sell |
1,223
-55
| -4% | -$17.2K | 0.04% | 419 |
|
|
2019
Q1 | $525K | Sell |
1,278
-832
| -39% | -$342K | 0.05% | 345 |
|
|
2018
Q4 | $788K | Sell |
2,110
-2,073
| -50% | -$774K | 0.08% | 244 |
|
|
2018
Q3 | $1.69M | Buy |
4,183
+11
| +0.3% | +$4.44K | 0.14% | 127 |
|
|
2018
Q2 | $1.44M | Buy |
+4,172
| New | +$1.44M | 0.13% | 126 |
|
|
2017
Q4 | – | Sell |
-799
| Closed | -$357K | – | 606 |
|
|
2017
Q3 | $357K | Hold |
799
| – | – | 0.05% | 291 |
|
|
2017
Q2 | $392K | Buy |
+799
| New | +$392K | 0.08% | 158 |
|